Cardiac medical therapy in patients after undergoing coronary artery bypass graft surgery: A review of randomized controlled trials

Journal of the American College of Cardiology

Volumn 45, Issue 2, 2005, Pages 177-184

  Okrainec, Karen ^a   Platt, Robert ^b   Pilote, Louise ^c   Eisenberg, Mark J ^d  

^a MCGILL UNIVERSITY   (Canada)

^b MONTREAL CHILDREN S HOSPITAL   (Canada)

^c MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; COLESTIPOL; COLESTYRAMINE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; GEMFIBROZIL; METOPROLOL; MEVINOLIN; NICOTINIC ACID; NITRIC ACID DERIVATIVE; QUINAPRIL; WARFARIN;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; DISEASE COURSE; DRUG EFFICACY; GRAFT OCCLUSION; HUMAN; META ANALYSIS; OUTCOMES RESEARCH; POSTOPERATIVE CARE; PRIORITY JOURNAL; REVIEW;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTILIPEMIC AGENTS; ASPIRIN; CALCIUM CHANNEL BLOCKERS; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; FIBRINOLYTIC AGENTS; HUMANS; POSTOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIALS;

EID: 11844288393     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.09.065     Document Type: Review

References (43)

1. The Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina N Engl J Med 311 1984 1333 1339
2. E. Varnauskas European Coronary Surgery Study Group Twelve-year follow-up of survival in the randomized European coronary surgery study N Engl J Med 319 1988 332 337
3. CASS Principal Investigators and Associates Coronary Artery Surgery Study (CASS): a randomized trial of coronary artery bypass surgery Circulation 68 1983 939 950
4. H.N. Hultgren, P. Peduzzi, K. Detre, T. Takaro The 5-year effect of bypass surgery on relief of angina and exercise performance Circulation 72 1985 79 83
5. S. Yusuf, D. Zucker, P. Peduzzi Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomized trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration Lancet 344 1994 563 570
6. W.S. Weintraub, S.D. Clements Jr, L.V. Crisco Twenty-year survival after coronary artery surgery: an institutional perspective from Emory University Circulation 107 2003 1271 1277
7. R.P. Anderson, S.H. Rahimtoola, L. Bonchek, A. Starr The prognosis of patients with coronary artery disease after coronary bypass operations Circulation 50 1974 274 282
8. L. Campeau, D. Crochet, J. Lesperance, M.G. Bourassa, C.M. Grondin Postoperative changes in aortocoronary saphenous vein grafts revisited: angiographic studies at two weeks and at one year in two series of consecutive patients Circulation 52 1975 369 377
9. M.G. Bourassa, L. Campeau, J. Lesperance Effects of bypass surgery on the coronary circulation: incidence and effects of vein graft occlusion Cardiovasc Clin 8 1977 107 118
10. F.E. Kloster, E.L. Krmkau, L.W. Ritxmann, S.H. Rahimtoola, J. Rosch, P.H. Kanarek Coronary bypass for stable angina: a prospective randomized study N Engl J Med 300 1979 149 157
11. Antiplatelet Trialists' Collaboration Collaborative overview of randomized trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients BMJ 308 1994 81 106
12. Scandinavian Simvastatin Survival Study Group Randomised trial of cholesterol lowering in 4,444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
13. F.M. Sacks, M.A. Pfeffer, L.A. Moye., for the Cholesterol and Recurrent Events Trial Investigators The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels N Engl J Med 335 1996 1001 1009
14. M.A. Pfeffer, F.M. Sacks, L.A. Moye Cholesterol and recurrent events: a secondary prevention trial for normolipidemic patients CARE Investigators Am J Cardiol 76 1995 98C 106C
15. J.W. Jukema, A.V. Bruschke, A.J. Van Boven Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels: the Regression Growth Evaluation Statin Study (REGRESS) Circulation 91 1995 2528 2540
16. Norwegian Multicenter Study Group Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction N Engl J Med 304 1981 801 807
17. J. Chen, T.A. Marciniak, M.J. Radford, Y. Wang, H.M. Krumholz Beta-blocker therapy for secondary prevention of myocardial infarction in elderly diabetic patients: results from the National Cooperative Cardiovascular Project J Am Coll Cardiol 34 1999 1388 1394
18. MERIT-HF Study Group Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) Lancet 353 1999 2001 2007
19. CIBIS II Investigators and Committees The Cardiac Insufficiency Bisprolol Study II (CIBIS II): a randomised trial Lancet 353 1999 9 13
20. P.A. Heidenreich, K.M. McDonald, T. Hastie Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina JAMA 281 1999 1927 1936
21. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure Lancet 342 1993 821 828
22. The Heart Outcomes Prevention Evaluation Study Investigators Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients N Engl J Med 342 2000 145 153
23. ACE Inhibitor Myocardial Infarction Collaborative Group Indications for ACE inhibitors in the early treatment of acute myocardial infarction Circulation 97 1998 2202 2212
24. Antithrombotic Trialists' Collaboration Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high-risk patients BMJ 324 2002 71 86
25. ACC/AHA Task Force on Practice Guidelines Guidelines for coronary artery bypass graft surgery J Am Coll Cardiol 34 1999 1262 1346
26. S. Goldman, J. Copeland, T. Moritz Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy Results of a Veterans Administration Cooperative Study Circulation 80 1989 1190 1197
27. J.H. Chesebro, V. Fuster, L.R. Elveback Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations N Engl J Med 310 1984 209 214
28. S. Goldman, J. Copeland, T. Moritz Long-term graft patency (3 years) after coronary artery surgery Effects of aspirin: results of a VA cooperative study Circulation 89 1994 1138 1143
29. N. Brooks, J. Wright, M. Sturridge Randomised placebo controlled trial of aspirin and dipyridamole in the prevention of coronary vein graft occlusion Br Heart J 53 1985 201 207
30. T.P. Gavaghan, V. Gebski, D.W. Baron Immediate postoperative aspirin improves vein graft patency early and late after coronary artery bypass graft surgery A placebo-controlled, randomized study Circulation 83 1991 1526 1533
31. M.T. McEnany, E.W. Salzman, E.D. Mundth The effect of antithrombotic therapy on patency rates of saphenous vein coronary artery bypass grafts J Thorac Cardiovasc Surg 83 1982 81 89
32. G.V. Sharma, S.F. Khuri, M. Josa, E.D. Folland, A.F. Parisi The effect of antiplatelet therapy on saphenous vein coronary artery bypass graft patency Circulation 68 1983 II218 21
33. B.G. Brown, R.A. Cukingnan, T. DeRouen Improved graft patency in patients treated with platelet-inhibiting therapy after coronary bypass surgery Circulation 72 1985 138 146
34. The Post Coronary Artery Bypass Graft Trial Investigators The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts N Engl J Med 336 1997 153 162
35. G.L. Knatterud, Y. Rosenberg, L. Campeau Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial Post CABG Investigators Circulation 102 2000 157 165
36. M.H. Frick, M. Syvanne, M.S. Nieminen Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol Lopid Coronary Angiography Trial (LOCAT) study group Circulation 96 1997 2137 2143
37. D.H. Blankenhorn, R.L. Johnson, S.A. Nessim, S.P. Azen, M.E. Sanmarco, R.H. Selzer The Cholesterol Lowering Atherosclerosis Study (CLAS): design, methods, and baseline results Control Clin Trials 8 1987 356 387
38. L. Cashin-Hemphill, W.J. Mack, J.M. Pogoda, M.E. Sanmarco, S.P. Azen, D.H. Blankenhorn Beneficial effects of colestipol-niacin on coronary atherosclerosis A 4-year follow-up JAMA 264 1990 3013 3017
39. S.P. Azen, W.J. Mack, L. Cashin-Hemphill Progression of coronary artery disease predicts clinical coronary events Long-term follow-up from the Cholesterol Lowering Atherosclerosis Study Circulation 93 1996 34 41
40. H. Sjoland, K. Caidahl, L. Lurje, A. Hjalmarson, J. Herlitz Metoprolol treatment for two years after coronary bypass grafting: effects on exercise capacity and signs of myocardial ischemia Br Heart J 74 1995 235 241
41. MACB Study Group Effect of metoprolol on death and cardiac events during a 2-year period after coronary artery bypass grafting Eur Heart J 16 1995 1825 1832
42. M. Gaudino, F. Glieca, N. Luciani, F. Alessandrini, G. Possati Clinical and angiographic effects of chronic calcium channel blocker therapy continued beyond first postoperative year in patients with radial artery grafts Circulation 104; 2001 I64 I67
43. M. Oosterga, A.A. Voors, Y.M. Pinto Effects of Quinapril on Clinical Outcome After Coronary Artery Bypass Grafting (QUO VADIS study) Am J Cardiol 87 2001 542 546